About
Cellular Immunotherapy
Areas of Focus
Categories
Stem Cell & Cellular TherapyBiotech
Team (3)
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
35
By Phase
PHASE2/PHASE3: 1PHASE2: 1PHASE3: 1
By Status
WITHDRAWN: 2TERMINATED: 1COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT03605654Lead Sponsor
Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transplants
PHASE2/PHASE3Withdrawn
Started: Dec 31, 2024 · Completed: Oct 31, 2026
NCT03606746Lead Sponsor
Cellular Immunotherapy for Immune Tolerance in Past Recipients of HLA Zero-mismatch, Living Donor Kidney Transplants
PHASE2Withdrawn
Started: Dec 31, 2024 · Completed: Oct 31, 2025
NCT05010174Lead Sponsor
Long-term Safety Follow-up in Recipients Who Previously Received Medeor's Cellular Immunotherapy Products
N/ATerminated
5 participants
Started: May 11, 2022 · Completed: Apr 30, 2024
NCT03363945Lead Sponsor
Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants
PHASE3Completed
30 participants
Started: Mar 15, 2018 · Completed: Apr 11, 2024
Locations (1)
Headquarters
South SF, CA, United States
Map
Loading map...